181 related articles for article (PubMed ID: 18347939)
1. Prevention of chemotherapy-induced alopecia in rodent models.
Jimenez JJ; Roberts SM; Mejia J; Mauro LM; Munson JW; Elgart GW; Connelly EA; Chen Q; Zou J; Goldenberg C; Voellmy R
Cell Stress Chaperones; 2008; 13(1):31-8. PubMed ID: 18347939
[TBL] [Abstract][Full Text] [Related]
2. Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model.
Katikaneni R; Ponnapakkam T; Matsushita O; Sakon J; Gensure R
Anticancer Drugs; 2014 Jan; 25(1):30-8. PubMed ID: 24025564
[TBL] [Abstract][Full Text] [Related]
3. A novel rat model for chemotherapy-induced alopecia.
Wikramanayake TC; Amini S; Simon J; Mauro LM; Elgart G; Schachner LA; Jimenez JJ
Clin Exp Dermatol; 2012 Apr; 37(3):284-9. PubMed ID: 22409523
[TBL] [Abstract][Full Text] [Related]
4. Treatment with ImuVert/N-acetylcysteine protects rats from cyclophosphamide/cytarabine-induced alopecia.
Jiménez JJ; Huang HS; Yunis AA
Cancer Invest; 1992; 10(4):271-6. PubMed ID: 1628226
[TBL] [Abstract][Full Text] [Related]
5. Protection from chemotherapy-induced alopecia by 1,25-dihydroxyvitamin D3.
Jimenez JJ; Yunis AA
Cancer Res; 1992 Sep; 52(18):5123-5. PubMed ID: 1516070
[TBL] [Abstract][Full Text] [Related]
6. Protection from chemotherapy-induced alopecia in a rat model.
Hussein AM; Jimenez JJ; McCall CA; Yunis AA
Science; 1990 Sep; 249(4976):1564-6. PubMed ID: 2218498
[TBL] [Abstract][Full Text] [Related]
7. Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia.
Imanishi H; Tsuruta D; Tateishi C; Sugawara K; Paus R; Tsuji T; Ishii M; Ikeda K; Kunimoto H; Nakajima K; Jones JC; Kobayashi H
J Dermatol Sci; 2010 Apr; 58(1):43-54. PubMed ID: 20211547
[TBL] [Abstract][Full Text] [Related]
8. Protection against chemotherapy-induced alopecia by cyclosporin A in the newborn rat animal model.
Hussein AM; Stuart A; Peters WP
Dermatology; 1995; 190(3):192-6. PubMed ID: 7599379
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner.
Katikaneni R; Ponnapakkam T; Seymour A; Sakon J; Gensure R
Anticancer Drugs; 2014 Aug; 25(7):819-25. PubMed ID: 24710191
[TBL] [Abstract][Full Text] [Related]
10. The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivo.
Newcomb EW; Lukyanov Y; Schnee T; Esencay M; Fischer I; Hong D; Shao Y; Zagzag D
Anticancer Drugs; 2007 Sep; 18(8):875-82. PubMed ID: 17667592
[TBL] [Abstract][Full Text] [Related]
11. Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors.
Davis ST; Benson BG; Bramson HN; Chapman DE; Dickerson SH; Dold KM; Eberwein DJ; Edelstein M; Frye SV; Gampe RT; Griffin RJ; Harris PA; Hassell AM; Holmes WD; Hunter RN; Knick VB; Lackey K; Lovejoy B; Luzzio MJ; Murray D; Parker P; Rocque WJ; Shewchuk L; Veal JM; Walker DH; Kuyper LF
Science; 2001 Jan; 291(5501):134-7. PubMed ID: 11141566
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
[TBL] [Abstract][Full Text] [Related]
13. 17-AAG improves cognitive process and increases heat shock protein response in a model lesion with Aβ25-35.
Ortega L; Calvillo M; Luna F; Pérez-Severiano F; Rubio-Osornio M; Guevara J; Limón ID
Neuropeptides; 2014 Aug; 48(4):221-32. PubMed ID: 24819277
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway.
Kimura T; Uesugi M; Takase K; Miyamoto N; Sawada K
Toxicol Appl Pharmacol; 2017 Aug; 329():282-292. PubMed ID: 28624441
[TBL] [Abstract][Full Text] [Related]
15. A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.
Pacey S; Gore M; Chao D; Banerji U; Larkin J; Sarker S; Owen K; Asad Y; Raynaud F; Walton M; Judson I; Workman P; Eisen T
Invest New Drugs; 2012 Feb; 30(1):341-9. PubMed ID: 20683637
[TBL] [Abstract][Full Text] [Related]
16. Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice.
Chen SS; Zhang Y; Lu QL; Lin Z; Zhao Y
Environ Toxicol Pharmacol; 2016 Sep; 46():270-276. PubMed ID: 27522546
[TBL] [Abstract][Full Text] [Related]
17. Cancer research. Preventing hair loss from chemotherapy.
Marx J
Science; 2001 Jan; 291(5501):25-6. PubMed ID: 11191992
[No Abstract] [Full Text] [Related]
18. Protection from chemotherapy-induced alopecia by docosahexaenoic acid.
Takahata K; Tada M; Yazawa K; Tamaki T
Lipids; 1999; 34 Suppl():S105. PubMed ID: 10419109
[No Abstract] [Full Text] [Related]
19. 17-allylamino-17-demethoxygeldanamycin and MEK1/2 inhibitors kill GI tumor cells via Ca2+-dependent suppression of GRP78/BiP and induction of ceramide and reactive oxygen species.
Walker T; Mitchell C; Park MA; Yacoub A; Rahmani M; Häussinger D; Reinehr R; Voelkel-Johnson C; Fisher PB; Grant S; Dent P
Mol Cancer Ther; 2010 May; 9(5):1378-95. PubMed ID: 20442308
[TBL] [Abstract][Full Text] [Related]
20. Role of increased vascular permeability in chemotherapy-induced alopecia: In vivo imaging of the hair follicular microenvironment in mice.
Sagawa N; Oshima Y; Hiratsuka T; Kono Y; Etoh T; Inomata M
Cancer Sci; 2020 Jun; 111(6):2146-2155. PubMed ID: 32227405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
